172 related articles for article (PubMed ID: 35771088)
1. Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients.
Andrews L; Benken J; Benedetti E; Nishioka H; Pierce D; Dalton K; Han J; Shin B; Benken S
Clin Transplant; 2022 Sep; 36(9):e14754. PubMed ID: 35771088
[TBL] [Abstract][Full Text] [Related]
2. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.
Wong A; Alkazemi A; Eche IM; Petri CR; Sarge T; Cocchi MN
J Intensive Care Med; 2020 Dec; 35(12):1490-1496. PubMed ID: 31480886
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine Vasopressor Exposure Is Associated With Early Poor Allograft Function and Adverse Events in Living Donor Kidney Transplant Recipients.
Thomas R; Benken J; Belcher RM; Palmer ME; Benedetti E; Benken ST
Transplant Proc; 2023 Sep; 55(7):1543-1550. PubMed ID: 37414695
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.
Bokoch MP; Tran AT; Brinson EL; Marcus SG; Reddy M; Sun E; Roll GR; Pardo M; Fields S; Adelmann D; Kothari RP; Legrand M
BMJ Open; 2023 Nov; 13(11):e078713. PubMed ID: 37984940
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
Allen JM; Gilbert BW
Clin Ther; 2019 Dec; 41(12):2594-2610. PubMed ID: 31668356
[TBL] [Abstract][Full Text] [Related]
7. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N
Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016
[TBL] [Abstract][Full Text] [Related]
8. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY.
See EJ; Clapham C; Liu J; Khasin M; Liskaser G; Chan JW; Serpa Neto A; Costa Pinto R; Bellomo R
Shock; 2023 May; 59(5):691-696. PubMed ID: 36930693
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU.
Quan M; Cho N; Bushell T; Mak J; Nguyen N; Litwak J; Rockwood N; Nguyen HB
Crit Care Explor; 2022 Jan; 4(1):e0623. PubMed ID: 35072084
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
[No Abstract] [Full Text] [Related]
11. Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis.
Carà GA; Pasin L; Alborino E; Zarbock A; Bellomo R; Landoni G
J Cardiothorac Vasc Anesth; 2022 Dec; 36(12):4496-4500. PubMed ID: 35995637
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
[TBL] [Abstract][Full Text] [Related]
13. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
14. Early vs. Late Vassopressor therapy in the Management of Patients with Sepsis and Hypotension, A Multicenter Observational Study.
Kusakabe A; Sweeny A; Keijzers G;
Arch Med Res; 2021 Nov; 52(8):836-842. PubMed ID: 34275667
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
[TBL] [Abstract][Full Text] [Related]
16. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
[TBL] [Abstract][Full Text] [Related]
17. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
Chawla LS; Ostermann M; Forni L; Tidmarsh GF
Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin II in treatment of refractory distributive shock.
Rodriguez R; Fernandez EM
Am J Health Syst Pharm; 2019 Jan; 76(2):101-107. PubMed ID: 31361800
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II in the treatment of distributive shock: a systematic-review and meta-analysis.
Xourgia E; Exadaktylos AK; Chalkias A; Ziaka M
Shock; 2024 Jun; ():. PubMed ID: 38888542
[TBL] [Abstract][Full Text] [Related]
20. Preinduction hemodynamic fluctuations in renal transplant recipients--comparison of two combined anesthesia regimens.
Sen I; Thomas S; Arya VK; Minz M
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1232-9. PubMed ID: 25394440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
